The city of Los Angeles, California, currently has 2 active clinical trials seeking participants for COPD research studies.
SPIROMICS Study of Early COPD Progression (SOURCE)
NCT05033990
Recruiting
This is an observational study of 1000 participants to further define the nature of early chronic obstructive pulmonary disease (COPD) in younger, at-risk individuals. The study has three main goals: To use CT scan imaging to identify which smokers will develop COPD. To identify biomarkers predictive of smokers that will develop COPD. To determine if sputum (phlegm) can be analyzed to predict which smokers will develop COPD. Procedures (methods): All participants will undergo study related qu... Read More
Gender:
All
Ages:
Between 30 years and 55 years
Trial Updated:
03/25/2024
Locations: University of California Los Angeles, Los Angeles, California
Conditions: COPD, Early-Onset
Register for Updates
Revefenacin in Acute Respiratory Insufficiency in COPD
NCT04315558
Recruiting
RARICO is a pragmatic, randomized, controlled, double-blinded, multi-center trial evaluating the safety and feasibility of nebulized revefenacin in comparison to nebulized ipratropium in patients with COPD and acute respiratory failure requiring invasive mechanical ventilation.
Gender:
All
Ages:
40 years and above
Trial Updated:
12/01/2023
Locations: Ronald Reagan Medical Center at UCLA, Los Angeles, California
Conditions: COPD, Acute Respiratory Failure
Register for Updates